소변 검사 시장 : 제품별, 용도별, 최종 사용자별, 지역별, 기회 및 예측(2017-2031년)

Global urinalysis market is projected to witness a CAGR of 5.77% during the forecast period 2024-2031, growing from USD 4.11 billion in 2023 to USD 6.44 billion in 2031.

The significant expansion of the global urinalysis market stems from various driving forces, such as growing demand for at-home testing, collaborative endeavors among major companies, favorable technological advancements, emphasis on preventive healthcare, and a rise in chronic ailments, especially among aging demographics.

There is a rising inclination toward at-home urinalysis devices, driven by the public's preference for self-care and tailored health management. These user-friendly tools enable independent health monitoring, facilitating early identification and handling of potential health issues. Partnerships between key industry players stimulate joint innovation, combining expertise, resources, and technological prowess. Such partnerships foster the advancement of sophisticated urinalysis solutions, broadening the global urinalysis market presence and enriching product offerings. Continuous advancements, notably in artificial intelligence (AI), automation, and portable devices, transform the landscape of urinalysis. These advancements notably enhance diagnostic processes' speed, precision, and convenience, thereby empowering both healthcare providers and individuals.

Healthcare trends increasingly focus on preventive measures, encouraging the adoption and development of urinalysis tools for early disease detection. Proactive health monitoring aligns with the aim of preventing illnesses before they escalate. The upsurge in chronic illnesses, combined with a globally aging population, drives the necessity for frequent urinalysis. With age-related health concerns rising, the demand intensifies for efficient and precise diagnostic instruments, propelling the expansion of the global urinalysis market. These interconnected elements collectively propel the dynamic growth of the global urinalysis market, molding it to cater to the evolving healthcare requisites of individuals and communities worldwide.

Increasing Focus on Preventive Healthcare

The growing emphasis on preventive healthcare significantly drives the expansion of the global urinalysis market. This focus stimulates the creation and application of urinalysis solutions for early disease detection. Urinalysis plays a crucial role in preventive healthcare by identifying potential health issues, enabling swift interventions, and halting disease progression. With healthcare models prioritizing prevention, there's an increased demand for precise urinalysis tools. This heightened demand solidifies their importance, establishing them as vital components in advancing worldwide healthcare strategies focused on proactive health management. Urinalysis contributes to the transition from reactive to proactive healthcare, fostering an ethos of early detection and intervention to enhance global health outcomes.

Technological Advancements

Technological advancements, particularly AI, are vital in driving the global urinalysis market. AI's incorporation brings about a revolution in urinalysis by significantly improving the accuracy, efficiency, and speed of analyzing and interpreting test results. By employing machine learning (ML) algorithms, AI rapidly recognizes patterns, irregularities, and potential health markers present in urine samples. This innovative technology streamlines diagnostic procedures, enabling faster and more precise identification of diseases or ailments. AI's capacity to learn and adapt enhances diagnostic capabilities, fostering a transition towards more tailored and efficient healthcare solutions. Its integration is pivotal in advancing urinalysis, amplifying its influence within global healthcare frameworks.

For example, in September 2022, the Israeli medical device startup Olive Diagnostics introduced a urinalysis equipment driven by artificial intelligence. The flagship product from Olive Diagnostics, Olive KG, is the first AI- and spectroscopy-based gadget in the world. It provides high-quality analysis of significant parameters in the patient's urine during each urination in a completely passive manner and doesn't require any further attachments.

Growing Popularity of Automated Urine Sediment Analyzer

The increasing adoption of automated urine sediment analyzers significantly boosts the global urinalysis market. These sophisticated systems streamline urine sample analysis by automating sediment examination, leading to heightened precision, speed, and effectiveness in identifying irregularities, thus facilitating faster and more accurate diagnoses. Furthermore, automation minimizes manual errors and labor-intensive processes, elevating reliability and throughput. This surge in usage mirrors the healthcare sector's amplified need for swift, precise, and consistent urinalysis, establishing automated urine sediment analyzers as crucial drivers behind the market's growth.

For instance, the world's first smart toilet clip-on device that would aid in the early diagnosis of health concerns was revealed by the wellness application Vivoo in January 2023. Launched at CES 2023 in Las Vegas, the smart toilet clip-on device can be added to current toilets and includes a urine strip in its seat. The risk of mess that can arise from handheld urine strips is eliminated when the strip automatically moves to align with the user's urine stream.

Growing Demand for At-home Devices

The increasing desire for at-home urinalysis devices is a significant driving force behind the global urinalysis market. These compact tools align with the growing trend of personalized healthcare, granting individuals the convenience of self-monitoring. Offering ease, precision, and instant insights, these devices empower users to oversee diverse health indicators within their home environment. Advancements in technology ensure accessible and prompt results, promoting proactive health maintenance. The rising inclination toward self-tracking and preventive healthcare further emphasizes the necessity for at-home urinalysis devices, establishing them as pivotal contributors to expanding the global urinalysis market.

For example, in January 2023, the medical device company Starling Medical announced the debut of StarStream, an at-home urine diagnostic patient monitoring platform. In contrast to traditional collection receptacles or dipsticks, StarStream examines the urine sample immediately.

Future Market Scenario (2024-2031F)

The future of the global urinalysis market looks promising, driven by several key factors. Technological advancements in AI and automation continually refine and improve urinalysis capabilities, enhancing diagnostic precision and efficiency. Growing demand for at-home testing devices and the emphasis on preventive healthcare further boost the growth of the global urinalysis market, meeting the demand for convenient proactive health monitoring solutions. Collaborations among industry leaders foster innovation, facilitating the development of sophisticated urinalysis tools. With an aging population and a rise in chronic conditions, the necessity for reliable and rapid diagnostic methods intensifies, strengthening the market's potential. These factors position the global urinalysis market for sustained expansion, addressing evolving healthcare needs and propelling advancements in diagnostic technologies worldwide for enhanced healthcare outcomes.

Key Players Landscape and Outlook

Large corporations in the global urinalysis market are progressively choosing to collaborate, merging their strengths. Through this union, these firms combine resources, research capabilities, and knowledge, nurturing innovation and broadening market reach. Such joint endeavors frequently result in the creation of state-of-the-art diagnostic technologies, innovative testing approaches, and improved product ranges. These partnerships also ease entry into new markets, stimulating growth and competitiveness. Ultimately, these collaborations cultivate a synergy that enables companies to better address evolving healthcare demands, delivering advanced urinalysis solutions on a global scale in a more comprehensive and efficient manner.

For example, in May 2023, Boehringer announced its partnership with Healthy.io to develop the first at-home, smartphone-based diagnostic tool, known as Minuteful Kidney Test, for screening individuals for chronic kidney disease (CKD). The traditional albumin-to-creatinine ratio (ACR) test, which finds protein in the urine and may indicate kidney disease at earlier stages, can be performed using the Minuteful Kidney test.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Urinalysis Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. Value
  • 4.1.2. Volume
• 4.2. By Product
  • 4.2.1. Instruments
    • 4.2.1.1. Automated Urine Sediment Analyzer
    • 4.2.1.2. Biochemical Urine Analyzer
  • 4.2.2. Consumables
    • 4.2.2.1. Reagents
    • 4.2.2.2. Dipsticks
    • 4.2.2.3. Disposables
• 4.3. By Application
  • 4.3.1. Urinary Tract Infections (UTI)
  • 4.3.2. Diabetes
  • 4.3.3. Pregnancy
  • 4.3.4. Kidney Disease
  • 4.3.5. Others
• 4.4. By End-user
  • 4.4.1. Hospitals
  • 4.4.2. Home Healthcare
  • 4.4.3. Clinical Laboratories
  • 4.4.4. Others
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. South America
  • 4.5.4. Asia-Pacific
  • 4.5.5. Middle East and Africa
• 4.6. By Company Market Share (%), 2023

5. Global Urinalysis Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. Value
    • 5.1.1.2. Volume
  • 5.1.2. By Product
    • 5.1.2.1. Instruments
    • 5.1.2.1.1. Automated Urine Sediment Analyzer
    • 5.1.2.1.2. Biochemical Urine Analyzer
    • 5.1.2.2. Consumables
    • 5.1.2.2.1. Reagents
    • 5.1.2.2.2. Dipsticks
    • 5.1.2.2.3. Disposables
  • 5.1.3. By Application
    • 5.1.3.1.1. Urinary Tract Infections (UTI)
    • 5.1.3.1.2. Diabetes
    • 5.1.3.1.3. Pregnancy
    • 5.1.3.1.4. Kidney Disease
    • 5.1.3.1.5. Others
  • 5.1.4. By End-user
    • 5.1.4.1.1. Hospitals
    • 5.1.4.1.2. Home Healthcare
    • 5.1.4.1.3. Clinical Laboratories
    • 5.1.4.1.4. Others
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
    • 5.1.5.1.1. Value
    • 5.1.5.1.2. Volume
    • 5.1.5.2. By Product
    • 5.1.5.2.1. Instruments
    • 5.1.5.2.1.1. Automated Urine Sediment Analyzer
    • 5.1.5.2.1.2. Biochemical Urine Analyzer
    • 5.1.5.2.2. Consumables
    • 5.1.5.2.2.1. Reagents
    • 5.1.5.2.2.2. Dipsticks
    • 5.1.5.2.2.3. Disposables
    • 5.1.5.3. By Application
    • 5.1.5.3.1. Urinary Tract Infections (UTI)
    • 5.1.5.3.2. Diabetes
    • 5.1.5.3.3. Pregnancy
    • 5.1.5.3.4. Kidney Disease
    • 5.1.5.3.5. Others
    • 5.1.5.4. By End-user
    • 5.1.5.4.1. Hospitals
    • 5.1.5.4.2. Home Healthcare
    • 5.1.5.4.3. Clinical Laboratories
    • 5.1.5.4.4. Others
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. South America
  • 5.3.1. Brazil
  • 5.3.2. Argentina
• 5.4. Asia-Pacific
  • 5.4.1. India
  • 5.4.2. China
  • 5.4.3. Japan
  • 5.4.4. Australia
  • 5.4.5. Vietnam
  • 5.4.6. South Korea
  • 5.4.7. Indonesia
  • 5.4.8. Philippines
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Products
• 6.2. By Application
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts, Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. F. Hoffmann-La Roche Ltd.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Danaher Corporation
• 13.3. Cardinal Health, Inc.
• 13.4. Sysmex Corporation
• 13.5. Quidel Corporation
• 13.6. Siemens Healthineers AG
• 13.7. Thermo Fisher Scientific Inc.
• 13.8. Abbott Laboratories
• 13.9. Bio-Rad Laboratories, Inc.
• 13.10. EKF Diagnostics
• 13.11. Becton, Dickinson and Company

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer